Trademark: 87643107
Status Date
Monday, August 16, 2021
Filing Date
Thursday, October 12, 2017
Published for Opposition
Tuesday, March 20, 2018
Abandoned Date
Monday, August 16, 2021
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Aug 16, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 16, 2021
Abandonment - No Use Statement Filed
Jan 5, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2021
Extension 5 Granted
Dec 16, 2020
Extension 5 Filed
Jan 4, 2021
Case Assigned To Intent To Use Paralegal
Dec 16, 2020
Teas Extension Received
Jul 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 2, 2020
Extension 4 Granted
Jul 2, 2020
Extension 4 Filed
Jul 2, 2020
Teas Extension Received
Jan 9, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2020
Extension 3 Granted
Jan 7, 2020
Extension 3 Filed
Jan 7, 2020
Teas Extension Received
Jul 2, 2019
Teas Change Of Correspondence Received
Jul 4, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 2, 2019
Extension 2 Granted
Jul 2, 2019
Extension 2 Filed
Jul 2, 2019
Teas Extension Received
Jan 8, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2019
Extension 1 Granted
Jan 4, 2019
Extension 1 Filed
Jan 4, 2019
Teas Extension Received
Jul 10, 2018
Noa E-Mailed - Sou Required From Applicant
May 30, 2018
Extension Of Time To Oppose Process - Terminated
May 7, 2018
Changes/Corrections After Pub Approval Entered
May 4, 2018
Assigned To Petition Staff
Apr 18, 2018
Teas Change Of Correspondence Received
Apr 18, 2018
Teas Post Publication Amendment Received
Apr 6, 2018
Extension Of Time To Oppose Received
Mar 20, 2018
Official Gazette Publication Confirmation E-Mailed
Mar 20, 2018
Published For Opposition
Feb 28, 2018
Notification Of Notice Of Publication E-Mailed
Feb 5, 2018
Approved For Pub - Principal Register
Jan 30, 2018
Teas/Email Correspondence Entered
Jan 30, 2018
Correspondence Received In Law Office
Jan 30, 2018
Teas Response To Office Action Received
Jan 23, 2018
Notification Of Non-Final Action E-Mailed
Jan 23, 2018
Non-Final Action E-Mailed
Jan 23, 2018
Non-Final Action Written
Jan 22, 2018
Assigned To Examiner
Oct 20, 2017
New Application Office Supplied Data Entered In Tram
Oct 16, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
